January 21, 2026
Gold medal winner at SIVAL, Amoéba displays its ambitions for its biocontrol solution
Chassieu, Jan. 20, 2026 (GLOBE NEWSWIRE) — Chassieu (France), 20 January 2026 – 6:00 pm – Amoéba (FR0011051598 – ALMIB),…
Pharmaceuticals, Biotechnology and Life Sciences
Chassieu, Jan. 20, 2026 (GLOBE NEWSWIRE) — Chassieu (France), 20 January 2026 – 6:00 pm – Amoéba (FR0011051598 – ALMIB),…
FORT LAUDERDALE, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM) (“Protext” “TXTM” or the “Company”) is…
Half-Year Report on Liquidity Contract with Invest Securities NANTES, France – January 20, 2026, 6:00pm CET – Under the liquidity contract…
PRESS RELEASE Shares concerned: Carbios (ISIN code: FR0011648716)Market concerned: Euronext Growth Paris Clermont-Ferrand, France, January 20, 2026 (6:00 pm CET).…
BOSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead…
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated…
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) — Orphai Therapeutics Inc. (“Orphai”), a clinical-stage biopharmaceutical company dedicated to advancing…
Company implements next growth stage following successful strategic and operational developmentUwe Buecheler, PhD, Vice Chairman of the Supervisory Board, appointed…
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung…
The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment…